NO992090L - Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav - Google Patents
Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse deravInfo
- Publication number
- NO992090L NO992090L NO992090A NO992090A NO992090L NO 992090 L NO992090 L NO 992090L NO 992090 A NO992090 A NO 992090A NO 992090 A NO992090 A NO 992090A NO 992090 L NO992090 L NO 992090L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- hydrophobic
- protein conjugate
- amino acids
- porcine protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 241001481760 Erethizon dorsatum Species 0.000 abstract 1
- 102000003693 Hedgehog Proteins Human genes 0.000 abstract 1
- 108090000031 Hedgehog Proteins Proteins 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229920006395 saturated elastomer Chemical group 0.000 abstract 1
- 229930195734 saturated hydrocarbon Chemical group 0.000 abstract 1
- -1 thio compound Chemical class 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98107911A EP0953575A1 (fr) | 1998-04-30 | 1998-04-30 | Conjugué de proteine hedgehog active, procédé pour sa production et utilisation |
| EP98116733 | 1998-09-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992090D0 NO992090D0 (no) | 1999-04-29 |
| NO992090L true NO992090L (no) | 1999-11-01 |
Family
ID=26149214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992090A NO992090L (no) | 1998-04-30 | 1999-04-29 | Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US6468978B1 (fr) |
| EP (2) | EP0953576B1 (fr) |
| JP (1) | JP3433136B2 (fr) |
| KR (1) | KR19990083621A (fr) |
| CN (1) | CN1233616A (fr) |
| AT (1) | ATE308563T1 (fr) |
| AU (1) | AU719797B2 (fr) |
| CA (1) | CA2269221A1 (fr) |
| CY (1) | CY1105683T1 (fr) |
| DE (1) | DE69928040T2 (fr) |
| DK (1) | DK0953576T3 (fr) |
| ES (1) | ES2252886T3 (fr) |
| HU (1) | HUP9901411A2 (fr) |
| IL (1) | IL129620A (fr) |
| MA (1) | MA26625A1 (fr) |
| NO (1) | NO992090L (fr) |
| NZ (1) | NZ335385A (fr) |
| SG (1) | SG80028A1 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136230A0 (en) * | 1997-11-28 | 2001-05-20 | Roche Diagnostics Gmbh | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| US6897297B1 (en) * | 1997-12-03 | 2005-05-24 | Curis, Inc. | Hydrophobically-modified protein compositions and methods |
| DK0953576T3 (da) * | 1998-04-30 | 2006-03-20 | Curis Inc | Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse |
| DE69928472T2 (de) | 1998-08-07 | 2006-08-10 | Curis, Inc., Cambridge | Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung |
| TW570805B (en) * | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| IL143403A0 (en) * | 1998-12-03 | 2002-04-21 | Biogen Inc | Methods and compositions for treating disorders involving excitotoxicity |
| EP1025861A1 (fr) * | 1999-02-04 | 2000-08-09 | Roche Diagnostics GmbH | Compositions pharmaceutiques des Proteines Hedgehog rendues hydrophobes, et leur utilisation |
| EP1183271A1 (fr) * | 1999-06-01 | 2002-03-06 | Biogen, Inc. | Conjugues polymeres de proteines hedgehog et leurs utilisations |
| AU2001255767A1 (en) * | 2000-04-28 | 2001-11-12 | Curis, Inc. | Methods and reagents for tissue engineering of cartilage in vitro |
| US7573637B2 (en) * | 2004-08-03 | 2009-08-11 | Seiko Epson Corporation | Intrinsic polarizer and method of manufacturing an intrinsic polarizer |
| US8669418B2 (en) * | 2005-12-22 | 2014-03-11 | Vib Vzw | Means and methods for mediating protein interference |
| WO2009108868A2 (fr) * | 2008-02-27 | 2009-09-03 | Radiomedix Inc. | Dérivés hedgehog radiomarqués utilisés en imagerie et en thérapie |
| US20100172889A1 (en) * | 2008-12-05 | 2010-07-08 | Catchmark Jeffrey M | Degradable biomolecule compositions |
| US20110086236A1 (en) * | 2009-10-13 | 2011-04-14 | The Penn State Research Foundation | Composites containing polypeptides attached to polysaccharides and molecules |
| TW201542231A (zh) * | 2011-06-06 | 2015-11-16 | Kineta One Llc | 以ｓｈｋ為主之醫藥組合物及其製備方法及用途 |
| EP3024887B1 (fr) | 2013-07-26 | 2023-11-22 | The Penn State Research Foundation | Procédé pour préparation des compositions et revêtements polymères |
| KR20170065016A (ko) * | 2015-12-02 | 2017-06-12 | 한미약품 주식회사 | 지방산 유도체를 이용한 단백질 결합체 및 이의 제조방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364839A (en) * | 1990-06-18 | 1994-11-15 | Genetics Institute, Inc. | Osteoinductive pharmaceutical formulations |
| EP0513334A4 (en) * | 1990-11-30 | 1993-08-04 | Celtrix Laboratories, Inc. | Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair |
| US5789543A (en) * | 1993-12-30 | 1998-08-04 | President And Fellows Of Harvard College | Vertebrate embryonic pattern-inducing proteins and uses related thereto |
| EP0741783B1 (fr) * | 1993-12-30 | 2009-03-18 | President And Fellows Of Harvard College | Proteines de type "hedgehog" induisant une structure embryonnaire chez les vertebres |
| US6281332B1 (en) * | 1994-12-02 | 2001-08-28 | The Johns Hopkins University School Of Medicine | Hedgehog-derived polypeptides |
| US5700774A (en) * | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
| GB9614871D0 (en) | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
| EP0966478A4 (fr) * | 1996-10-07 | 2002-08-21 | Univ Johns Hopkins Med | Nouveaux polypeptides derives d'une proteine herisson |
| IL136230A0 (en) * | 1997-11-28 | 2001-05-20 | Roche Diagnostics Gmbh | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| US6897297B1 (en) * | 1997-12-03 | 2005-05-24 | Curis, Inc. | Hydrophobically-modified protein compositions and methods |
| EE200000308A (et) * | 1997-12-03 | 2001-10-15 | Biogen, Inc. | Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid |
| DK0953576T3 (da) * | 1998-04-30 | 2006-03-20 | Curis Inc | Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse |
| DE69928472T2 (de) * | 1998-08-07 | 2006-08-10 | Curis, Inc., Cambridge | Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung |
| AU2001255767A1 (en) * | 2000-04-28 | 2001-11-12 | Curis, Inc. | Methods and reagents for tissue engineering of cartilage in vitro |
-
1999
- 1999-04-23 DK DK99108032T patent/DK0953576T3/da active
- 1999-04-23 ES ES99108032T patent/ES2252886T3/es not_active Expired - Lifetime
- 1999-04-23 DE DE69928040T patent/DE69928040T2/de not_active Expired - Fee Related
- 1999-04-23 EP EP99108032A patent/EP0953576B1/fr not_active Expired - Lifetime
- 1999-04-23 AT AT99108032T patent/ATE308563T1/de not_active IP Right Cessation
- 1999-04-23 EP EP05009341A patent/EP1557427A3/fr not_active Withdrawn
- 1999-04-26 NZ NZ335385A patent/NZ335385A/xx unknown
- 1999-04-27 IL IL129620A patent/IL129620A/en not_active IP Right Cessation
- 1999-04-28 HU HU9901411A patent/HUP9901411A2/hu unknown
- 1999-04-28 SG SG9902117A patent/SG80028A1/en unknown
- 1999-04-28 US US09/301,199 patent/US6468978B1/en not_active Expired - Fee Related
- 1999-04-29 CN CN99106302A patent/CN1233616A/zh active Pending
- 1999-04-29 MA MA25560A patent/MA26625A1/fr unknown
- 1999-04-29 KR KR1019990015503A patent/KR19990083621A/ko active IP Right Grant
- 1999-04-29 NO NO992090A patent/NO992090L/no not_active Application Discontinuation
- 1999-04-29 CA CA002269221A patent/CA2269221A1/fr not_active Abandoned
- 1999-04-29 AU AU25009/99A patent/AU719797B2/en not_active Ceased
- 1999-04-30 JP JP12500599A patent/JP3433136B2/ja not_active Expired - Fee Related
-
2002
- 2002-10-21 US US10/278,060 patent/US6818623B2/en not_active Expired - Fee Related
-
2004
- 2004-10-08 US US10/961,982 patent/US7153836B2/en not_active Expired - Fee Related
-
2006
- 2006-02-01 CY CY20061100133T patent/CY1105683T1/el unknown
- 2006-12-22 US US11/645,014 patent/US20070191274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO992090D0 (no) | 1999-04-29 |
| NZ335385A (en) | 2000-09-29 |
| JP3433136B2 (ja) | 2003-08-04 |
| HUP9901411A2 (hu) | 1999-12-28 |
| JP2000053699A (ja) | 2000-02-22 |
| IL129620A0 (en) | 2000-02-29 |
| US6468978B1 (en) | 2002-10-22 |
| CN1233616A (zh) | 1999-11-03 |
| EP1557427A3 (fr) | 2005-10-19 |
| US20070191274A1 (en) | 2007-08-16 |
| DE69928040D1 (de) | 2005-12-08 |
| US20050148510A1 (en) | 2005-07-07 |
| US6818623B2 (en) | 2004-11-16 |
| DE69928040T2 (de) | 2006-07-27 |
| MA26625A1 (fr) | 2004-12-20 |
| EP0953576A1 (fr) | 1999-11-03 |
| AU2500999A (en) | 1999-11-11 |
| EP1557427A2 (fr) | 2005-07-27 |
| ATE308563T1 (de) | 2005-11-15 |
| DK0953576T3 (da) | 2006-03-20 |
| CY1105683T1 (el) | 2010-12-22 |
| KR19990083621A (ko) | 1999-11-25 |
| US20030139574A1 (en) | 2003-07-24 |
| IL129620A (en) | 2009-06-15 |
| HU9901411D0 (en) | 1999-07-28 |
| AU719797B2 (en) | 2000-05-18 |
| ES2252886T3 (es) | 2006-05-16 |
| SG80028A1 (en) | 2001-04-17 |
| CA2269221A1 (fr) | 1999-10-30 |
| US7153836B2 (en) | 2006-12-26 |
| EP0953576B1 (fr) | 2005-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO992090L (no) | Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav | |
| Balhorn et al. | Mouse sperm chromatin proteins: quantitative isolation and partial characterization | |
| Dolphin et al. | Pertussis toxin reverses adenosine inhibition of neuronal glutamate release | |
| Hu et al. | An angiogenin-binding protein from endothelial cells. | |
| AU2022201708A1 (en) | Compounds and methods for inhibiting phosphate transport | |
| Segui‐Real et al. | Functional independence of the protein translocation machineries in mitochondrial outer and inner membranes: passage of preproteins through the intermembrane space. | |
| PT835262E (pt) | Metodo para o tratamento de osteopenia induzida por corticosteroides | |
| EP0748817A3 (fr) | Dérivés de l'hormone parathyrodienne et leur utilisation | |
| DE69831007D1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
| Saks et al. | Specific inhibition of ATP-ADP translocase in cardiac mitoplasts by antibodies against mitochondrial creatine kinase | |
| Jensen et al. | Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists | |
| Forte et al. | Studies of kidney plasma membrane adenosine-3′, 5′-monophosphate-dependent protein kinase | |
| Tait et al. | Artificial low‐molecular‐mass substrates of cholera toxin | |
| DE10080849D2 (de) | Fragmente des Virus Proteins 2 oder 3 des Polymavirus als Fähren für Wirkstoffe | |
| Quist et al. | Modification of cardiac membrane adenylate cyclase activity and GSα by NAD and endogenous ADP-ribosyltransferase | |
| ES2084599T3 (es) | Metodo para purificar antitrombina iii y preparacion de antitrombina iii que contiene dicha antitrombina iii. | |
| Meiniel et al. | The complex-type glycoprotein secreted by the bovine subcommissural organ: an immunological study using C 1 B 8 A 8 monoclonal antibody | |
| PE20001068A1 (es) | Produccion de analogos de tripsinogeno recombinante solubles | |
| Elhammer et al. | Glycosylation of rat liver cytochrome b5 on the ribosomal level | |
| ATE358171T1 (de) | Hydrophobe aminosäuren enthaltende trockene zusammensetzung | |
| Haeger et al. | Diazobenzenesulphonate selectively abolishes stimulation of glucuronidation by UDP-N-acetylglucosamine | |
| HUP0100132A2 (hu) | A béta-lipotropin és felhasználása | |
| Gaikwad et al. | The use of chemical cross-linking to identify proteins that interact with a mitochondrial presequence. | |
| Agui et al. | Agonist-induced desensitization of the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland | |
| Lin-Shiau et al. | β-endorphin: characteristics of binding sites in the mouse brain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |